{"success":true,"data":{"pressRelease":{"id":"140229","rtpr_id":"nNFC2T4mgP-20260910","ticker":"EK","exchange":"","all_tickers":["EK"],"title":"Everkind Wellness Inc. Commences Trading on the Frankfurt Stock Exchange","author":"Newsfile Corp","published_at":"2026-09-10T11:30:14.669Z","article_body":"Secondary listing under the symbol CG30; TSX Venture Exchange trading\ncontinues unchanged, with no change to the Company's capital structure\n\nToronto, Ontario--(Newsfile Corp. - September 10, 2026) - Everkind Wellness\nInc. (TSXV: EK) (FSE: CG30) (the \"Company\" or \"Everkind\"), a wellness platform\nbuilt for emotional self-care, today announced that its common shares have\ncommenced trading on the Frankfurt Stock Exchange (the \"FSE\") under the symbol\n\"CG30\" (WKN: A42J3E).\n\nThe Frankfurt listing is a secondary listing. Everkind's common shares\ncontinue to trade on the TSX Venture Exchange, which remains the Company's\nprimary listing. No new shares were issued and no capital was raised with the\nlisting.\n\nThe Frankfurt Stock Exchange is one of the world's largest and most\nestablished trading venues by market capitalization. The Company's stock\nquotation on the FSE is aimed to increase the Company's visibility and\naccessibility among European and international investors.\n\nAbout Everkind Wellness Inc.\n\nEverkind Wellness Inc. is a Toronto-based emotional wellness company making\nmental and emotional support accessible, affordable, and stigma-free. Its\nplatform combines AI-powered journaling and personalized meditations, acting\nas an intelligent companion that learns and adapts with each user. Private,\nnon-clinical, and designed for real life. Learn more at www.everkind.com.\n\nFor further information:\n\nHarrison Newlands, Chief Executive Officer - hello@everkind.com - 647-366-2795\n\nThis news release does not constitute an offer to sell, or a solicitation of\nan offer to buy, any securities in the United States. The Company's securities\nhave not been and will not be registered under the United States Securities\nAct of 1933, as amended, or any state securities laws, and may not be offered\nor sold within the United States or to U.S. persons absent registration or an\napplicable exemption from such registration requirements.\n\nFORWARD-LOOKING STATEMENTS\n\nThis press release contains forward-looking statements and forward-looking\ninformation within the meaning of applicable securities laws. The use of any\nof the words \"expect\", \"anticipate\", \"continue\", \"estimate\", \"objective\",\n\"ongoing\", \"may\", \"will\", \"project\", \"should\", \"believe\", \"plans\", \"intends\"\nand similar expressions are intended to identify forward-looking information\nor statements. The forward-looking statements and information are based on\ncertain key expectations and assumptions made by the Company. Although the\nCompany believes that the expectations and assumptions on which such\nforward-looking statements and information are based are reasonable, undue\nreliance should not be placed on the forward-looking statements and\ninformation because the Company can give no assurance that they will prove to\nbe correct. By its nature, such forward-looking information is subject to\nvarious risks and uncertainties, which could cause the actual results and\nexpectations to differ materially from the anticipated results or expectations\nexpressed. Readers are cautioned not to place undue reliance on this\nforward-looking information, which is given as of the date hereof, and to not\nuse such forward-looking information for anything other than its intended\npurpose. These statements assume that the Company's shares continue to be\nquoted on the FSE, that European investor interest develops as anticipated,\nand that no material adverse change occurs in the Company's business or in\ngeneral market conditions. There is no assurance that the listing will result\nin increased visibility, trading volume or liquidity, that an active trading\nmarket will develop or be sustained on the FSE, or that the listing will\naffect the price of the Company's shares. The Company undertakes no obligation\nto update publicly or revise any forward-looking information, whether as a\nresult of new information, future events or otherwise, except as required by\nlaw.\n\nNeither TSX Venture Exchange nor its Regulation Services Provider (as that\nterm is defined in policies of the TSX Venture Exchange) accepts\nresponsibility for the adequacy or accuracy of this release.\n\nTo view the source version of this press release, please visit\nhttps://www.newsfilecorp.com/release/313727","article_body_html":"","raw_payload":{"data":{"id":"nNFC2T4mgP-20260910","title":"Everkind Wellness Inc. Commences Trading on the Frankfurt Stock Exchange","author":"Newsfile Corp","ticker":"EK","created":"2026-09-10T11:30:14.669Z","tickers":["EK"],"exchange":"","article_body":"Secondary listing under the symbol CG30; TSX Venture Exchange trading\ncontinues unchanged, with no change to the Company's capital structure\n\nToronto, Ontario--(Newsfile Corp. - September 10, 2026) - Everkind Wellness\nInc. (TSXV: EK) (FSE: CG30) (the \"Company\" or \"Everkind\"), a wellness platform\nbuilt for emotional self-care, today announced that its common shares have\ncommenced trading on the Frankfurt Stock Exchange (the \"FSE\") under the symbol\n\"CG30\" (WKN: A42J3E).\n\nThe Frankfurt listing is a secondary listing. Everkind's common shares\ncontinue to trade on the TSX Venture Exchange, which remains the Company's\nprimary listing. No new shares were issued and no capital was raised with the\nlisting.\n\nThe Frankfurt Stock Exchange is one of the world's largest and most\nestablished trading venues by market capitalization. The Company's stock\nquotation on the FSE is aimed to increase the Company's visibility and\naccessibility among European and international investors.\n\nAbout Everkind Wellness Inc.\n\nEverkind Wellness Inc. is a Toronto-based emotional wellness company making\nmental and emotional support accessible, affordable, and stigma-free. Its\nplatform combines AI-powered journaling and personalized meditations, acting\nas an intelligent companion that learns and adapts with each user. Private,\nnon-clinical, and designed for real life. Learn more at www.everkind.com.\n\nFor further information:\n\nHarrison Newlands, Chief Executive Officer - hello@everkind.com - 647-366-2795\n\nThis news release does not constitute an offer to sell, or a solicitation of\nan offer to buy, any securities in the United States. The Company's securities\nhave not been and will not be registered under the United States Securities\nAct of 1933, as amended, or any state securities laws, and may not be offered\nor sold within the United States or to U.S. persons absent registration or an\napplicable exemption from such registration requirements.\n\nFORWARD-LOOKING STATEMENTS\n\nThis press release contains forward-looking statements and forward-looking\ninformation within the meaning of applicable securities laws. The use of any\nof the words \"expect\", \"anticipate\", \"continue\", \"estimate\", \"objective\",\n\"ongoing\", \"may\", \"will\", \"project\", \"should\", \"believe\", \"plans\", \"intends\"\nand similar expressions are intended to identify forward-looking information\nor statements. The forward-looking statements and information are based on\ncertain key expectations and assumptions made by the Company. Although the\nCompany believes that the expectations and assumptions on which such\nforward-looking statements and information are based are reasonable, undue\nreliance should not be placed on the forward-looking statements and\ninformation because the Company can give no assurance that they will prove to\nbe correct. By its nature, such forward-looking information is subject to\nvarious risks and uncertainties, which could cause the actual results and\nexpectations to differ materially from the anticipated results or expectations\nexpressed. Readers are cautioned not to place undue reliance on this\nforward-looking information, which is given as of the date hereof, and to not\nuse such forward-looking information for anything other than its intended\npurpose. These statements assume that the Company's shares continue to be\nquoted on the FSE, that European investor interest develops as anticipated,\nand that no material adverse change occurs in the Company's business or in\ngeneral market conditions. There is no assurance that the listing will result\nin increased visibility, trading volume or liquidity, that an active trading\nmarket will develop or be sustained on the FSE, or that the listing will\naffect the price of the Company's shares. The Company undertakes no obligation\nto update publicly or revise any forward-looking information, whether as a\nresult of new information, future events or otherwise, except as required by\nlaw.\n\nNeither TSX Venture Exchange nor its Regulation Services Provider (as that\nterm is defined in policies of the TSX Venture Exchange) accepts\nresponsibility for the adequacy or accuracy of this release.\n\nTo view the source version of this press release, please visit\nhttps://www.newsfilecorp.com/release/313727"},"type":"article","timestamp":"2026-09-10T11:30:14.723178952Z","server_sent_at_ms":1789039814723},"received_at":"2026-09-10T11:30:14.780Z","source_url":"https://www.newsfilecorp.com/release/313727"},"analysis":{"id":"129063","press_release_id":"140229","analysis_json":{"industry":{"label":"Software","sector":"Information Technology"},"redFlags":["Company cautions there is no assurance the FSE listing will increase visibility, trading volume, or liquidity, or that an active trading market will develop on the FSE"],"eventType":"other","narrative":"Everkind Wellness' common shares commenced trading on the Frankfurt Stock Exchange on September 10, 2026 under the symbol CG30 (WKN A42J3E).\n\nThe Frankfurt listing is a secondary listing only — the TSX Venture Exchange remains the primary listing, no new shares were issued, and no capital was raised.\n\nManagement says the FSE quotation is aimed at increasing visibility and accessibility among European and international investors, though the company cautions there is no assurance that an active trading market will develop or be sustained on the FSE.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Dilution-free secondary FSE listing for a micro-cap wellness app — worth watching only if European volume actually materializes."},"keyFigures":{"customDimensions":{"wkn":"A42J3E","fse_symbol":"CG30","capital_raised":"none","new_shares_issued":0}},"quotedText":"The Frankfurt listing is a secondary listing.","namedEntities":{"people":[{"name":"Harrison Newlands","role":"Chief Executive Officer"}],"products":[],"companies":[{"name":"Everkind Wellness Inc.","ticker":"EK","relationship":"filer/issuer"},{"name":"Frankfurt Stock Exchange","relationship":"secondary listing venue"},{"name":"TSX Venture Exchange","relationship":"primary listing venue"}],"dollarAmounts":[]},"materialImpact":{"score":2,"reasoning":"A secondary listing on the Frankfurt Stock Exchange with no new shares issued and no capital raised is a routine corporate action. It offers only potential (unassured) benefits of European visibility and liquidity, with no change to the capital structure or financials."},"tickerRelevance":{"others":[{"ticker":"CG30","relevance":"secondary listing symbol of the same issuer (Everkind Wellness) on the Frankfurt Stock Exchange"}],"primary":"EK"},"globalImportance":10,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"micro-cap (TSXV)","eventGravity":"secondary listing, no capital raise","dilutionImpact":"none — no new shares issued","householdBrandBoost":false,"marketCapAdjustment":"negligible market impact expected","retailFavoriteBoost":false}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":2,"narrative":"Everkind Wellness' common shares commenced trading on the Frankfurt Stock Exchange on September 10, 2026 under the symbol CG30 (WKN A42J3E).\n\nThe Frankfurt listing is a secondary listing only — the TSX Venture Exchange remains the primary listing, no new shares were issued, and no capital was raised.\n\nManagement says the FSE quotation is aimed at increasing visibility and accessibility among European and international investors, though the company cautions there is no assurance that an active trading market will develop or be sustained on the FSE.","key_figures":{"customDimensions":{"wkn":"A42J3E","fse_symbol":"CG30","capital_raised":"none","new_shares_issued":0}},"named_entities":{"people":[{"name":"Harrison Newlands","role":"Chief Executive Officer"}],"products":[],"companies":[{"name":"Everkind Wellness Inc.","ticker":"EK","relationship":"filer/issuer"},{"name":"Frankfurt Stock Exchange","relationship":"secondary listing venue"},{"name":"TSX Venture Exchange","relationship":"primary listing venue"}],"dollarAmounts":[]},"model_name":"glm-5.3-flash","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-10T11:31:40.967Z","global_importance":10,"audience_relevance":10,"importance_components":{"tickerTier":"micro-cap (TSXV)","eventGravity":"secondary listing, no capital raise","dilutionImpact":"none — no new shares issued","householdBrandBoost":false,"marketCapAdjustment":"negligible market impact expected","retailFavoriteBoost":false}},"durationMs":34926,"modelName":"glm-5.3-flash"}}